Region: Global
Category: Life Sciences

Global Life Sciences

(44,991 reports matching your criteria)
  • Central Venous Catheters (CVCs)

    ... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Multi-Lumen CVCs, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$971.4 Million by the ... Read More

  • Digital Therapeutics

    ... CAGR of 27.9% over the analysis period 2024-2030. B2B Sales Channel, one of the segments analyzed in the report, is expected to record a 28.6% CAGR and reach US$32.9 Billion by the end of the ... Read More

  • ePRO, E-Patient Diaries and eCOA

    ... Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2024-2030. eClinical Outcome Assessments (eCOAs), one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach ... Read More

  • Infection Surveillance Solutions

    ... at a CAGR of 16.3% over the analysis period 2024-2030. Infection Surveillance Software, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$1.3 Billion by the end ... Read More

  • Long-Term Care Software

    ... at a CAGR of 10.8% over the analysis period 2024-2030. Electronic Health Records (EHR), one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$5.8 Billion by the ... Read More

  • Medical Device Reprocessing

    ... at a CAGR of 15.3% over the analysis period 2024-2030. Reprocessing Support & Services, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$3.7 Billion by the ... Read More

  • Patient Warming Devices

    ... at a CAGR of 6.1% over the analysis period 2024-2030. Surface Warming Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.3 Billion by the end ... Read More

  • Surgical Loupes and Cameras

    ... 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Surgical Loupes, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$443.8 Million by the ... Read More

  • Trampolines

    ... 5.2% over the analysis period 2024-2030. Round Trampolines, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth ... Read More

  • Otoscopes

    ... 4.0% over the analysis period 2024-2030. Pocket-Size Otoscopes, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$150.5 Million by the end of the analysis period. Growth ... Read More

  • Special Purpose Needles

    ... at a CAGR of 6.7% over the analysis period 2024-2030. Hypodermic Needles, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$6.9 Billion by the end of ... Read More

  • Medical Thermometers

    ... CAGR of 6.9% over the analysis period 2024-2030. Digital Thermometers, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$1.4 Billion by the end of the analysis ... Read More

  • Laboratory Refrigerators and Ovens

    ... 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. General Purpose Laboratory Refrigerators, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$656.3 Million ... Read More

  • Bipolar Disorder Therapeutics

    ... at a CAGR of 3.4% over the analysis period 2024-2030. Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by the end of ... Read More

  • Calibration Services

    ... CAGR of 5.6% over the analysis period 2024-2030. Electrical Calibration Services, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.2 Billion by the end of the ... Read More

  • Acute Myeloid Leukemia (AML) Therapeutics

    ... Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2024-2030. Cytarabine, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$592.7 Million by ... Read More

  • RFID in Healthcare

    ... at a CAGR of 14.6% over the analysis period 2024-2030. RFID Tags, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$8.5 Billion by the end of ... Read More

  • Biopharmaceutical Bioseparation Systems

    ... at a CAGR of 10.9% over the analysis period 2024-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$15.8 Billion by the end of ... Read More

  • Compression Therapy

    ... CAGR of 6.8% over the analysis period 2024-2030. Compression Bandages, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.9 Billion by the end of the analysis ... Read More

  • Home Healthcare Software

    ... at a CAGR of 14.1% over the analysis period 2024-2030. Home Healthcare Solutions, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$6.4 Billion by the end ... Read More

  • Immune Health Supplements

    ... at a CAGR of 8.5% over the analysis period 2024-2030. Vitamins, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$13.1 Billion by the end of the ... Read More

  • Biocompatible Materials

    ... CAGR of 15.7% over the analysis period 2024-2030. Polymeric Materials, one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$231.0 Billion by the end of the analysis ... Read More

  • Automotive Adaptive Cruise Control

    ... 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. RADAR, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$44.8 Billion by the end ... Read More

  • 3D Medical Imaging

    ... at a CAGR of 6.1% over the analysis period 2024-2030. CT Devices, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$8.9 Billion by the end of ... Read More

  • Animal Genetics

    ... CAGR of 5.8% over the analysis period 2024-2030. Live Animals, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$7.3 Billion by the end of the analysis ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings